News

Nasonex Will Be Available Over the Counter

March 18, 2022

Read More »

Novel Treatment Approved for Rare Form of Epilepsy

March 18, 2022

Read More »

Opdualag Combines Novel Antibody with Opdivo to Treat Melanoma

March 18, 2022

Read More »

Rinvoq Approved for Ulcerative Colitis

March 16, 2022

Read More »

Symbicort Generic Approved

March 15, 2022

Read More »

FDA Approves Transdermal Patch to Treat Alzheimer-Type Dementia

March 14, 2022

Read More »

Lynparza Receives First-in-Class Approval for Early Breast Cancer

March 11, 2022

Read More »

Teva Pharmaceuticals Launches First Revlimid Generic

March 8, 2022

Read More »

Opdivo Granted Additional Lung Cancer Indication

March 4, 2022

Read More »

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

Full Name(Required)

Email(Required)

Comment(Required)

Company Name(Required)

CAPTCHA